e-learning
resources
ERJ
2010
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Statins inhibit matrix metalloproteinase release from human lung fibroblasts
Kamio K, Liu X. D, Sugiura H, Togo S, Kawasaki S, Wang X, Ahn Y, Hogaboam C, Rennard S. I.
Source:
Eur Respir J 2010; 35: 637-646
Journal Issue:
March
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Kamio K, Liu X. D, Sugiura H, Togo S, Kawasaki S, Wang X, Ahn Y, Hogaboam C, Rennard S. I.. Statins inhibit matrix metalloproteinase release from human lung fibroblasts. Eur Respir J 2010; 35: 637-646
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Effusions related to TB
Laboratory diagnosis of tuberculosis
Related content which might interest you:
Biological role of matrix metalloproteinases: a critical balance
Source: Eur Respir J 2011; 37: 191-208
Year: 2011
Remodelling of extracellular matrix (ECM) differs between tumor centre and invasion front in human non-small cell lung cancer: immunohistochemistry and morphometry of matrix proteins (MP), matrix metalloproteinases (MMPs), and tissue inhibitors of MMPs (T
Source: Annual Congress 2008 - Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases
Year: 2008
Effects of keratinocyte growth factor (KGF) on matrix metalloproteinases (MMPs) & tissue inhibitors of metalloproteinases (TIMPs) mRNA levels in emphysematous rats lungs
Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD
Year: 2008
Effects of steroids and b-mimetics on matrix metalloproteinases expression in human lung primary cells
Source: Eur Respir J 2003; 22: Suppl. 45, 453s
Year: 2003
Remodelling of extracellular matrix (ECM) differs between pulmonary adenocarcinoma (Ad) and squamous cell carcinoma (Sq): immunohistochemistry and morphometry of matrix proteins (MPs), matrix metalloproteinases (MMPs), and tissue inhibitors of MMPs (TIMPs
Source: Annual Congress 2008 - Novel targets in the molecular pathology of lung cancer and COPD
Year: 2008
Pneumolysin induces release of matrix metalloproteinase-8 and -9 from human neutrophils
Source: Eur Respir J 2009; 34: 1167-1170
Year: 2009
Promotional effect of 27-hydroxycholesterol in the release of matrix metalloproteinases by lung fibroblasts
Source: Annual Congress 2013 –Stress responses and T-cell behaviour in the lung
Year: 2013
Regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases expression in the bronchial secretions of asthmatics and COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 92s
Year: 2002
Blood levels of matrix metalloproteinases (MMPs) and tissue inhibitors of matrix matalloproteinases (TIMPs) as biomarkers of COPD.
Source: International Congress 2018 – Functional genomics and COPD: new challenges
Year: 2018
Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF
Source: Eur Respir J 2002; 20: 1220-1227
Year: 2002
Expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in pleural effusions
Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions
Year: 2011
Matrix metalloproteinase (MMP)-2 production by fibroblasts and mast cells: the role in pulmonary fibrosis
Source: Eur Respir J 2004; 24: Suppl. 48, 455s
Year: 2004
Statins inhibit human lung fibroblast production and activation of MMPs
Source: Eur Respir J 2007; 30: Suppl. 51, 692s
Year: 2007
Gelatinase expression in pulmonary arteries during experimental pulmonary hypertension
Source: Eur Respir J 2001; 18: 838-845
Year: 2001
Effects of cyclic stretch on stiffness and matrix metalloproteinases (MMPs) in mouse lung tissue strips
Source: Annual Congress 2009 - Mechanisms of pulmonary inflammation and fibrosis
Year: 2009
A therapeutic role for matrix metalloproteinase inhibitors in lung diseases?
Source: Eur Respir J 2011; 38: 1200-1214
Year: 2011
Matrix metalloproteinases and their inhibitors in pulmonary hypertension},
Source: Eur Respir J 2012; 40: 766-782
Year: 2012
Suppression of matrix metalloproteinase production from nasal fibroblasts by macrolide antibiotics in vitro
Source: Eur Respir J 2004; 23: 671-678
Year: 2004
Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2005; 25: 834-842
Year: 2005
Extracellular matrix components and regulators in the airway smooth muscle in asthma
Source: Eur Respir J 2008; 32: 61-69
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept